Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Capecitabine + docetaxel improves survival in advanced breast cancer

July 16, 2002

Actimid shows antitumor activity in multiple myeloma

July 15, 2002

Enzon to reacquire Oncaspar rights from Aventis

July 15, 2002

Vertex presents new caspase inhibitors for use in cancer, etc.

July 15, 2002

Novel FTase inhibitors in early development at Janssen

July 15, 2002

Dyax acquires exclusive rights to a newly discovered prostate cancer target

July 15, 2002

Phase III patient enrollment complete for histrelin implant

July 15, 2002

Plans discussed for Exherin phase I clinical trials

July 12, 2002

MediciNova acquires worldwide rights to novel cancer treatment

July 12, 2002

Selective CCK2 antagonist undergoes clinical evaluation at JB for pancreatic cancer

July 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...